Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiPl (original) (raw)

Nature volume 389, pages 187–190 (1997)Cite this article

Abstract

Much of the predisposition to hereditary breast and ovarian cancer has been attributed to inherited defects in the BRCA1 tumour-suppressor gene1,2,3. The nuclear protein BRCA1 has the properties of a transcription factor4,5,6,7, and can interact with the recombination and repair protein RAD51 (ref. 8). Young women with germline alterations in BRCA1 develop breast cancer at rates 100-fold higher than the general population3, and _BRCA1_-null mice die before day 8 of development9,10. However, the mechanisms of _BRCA1_-mediated growth regulation and tumour suppression remain unknown. Here we show that BRCA1 transactivates expression of the cyclin-dependent kinase inhibitor p21WAF1/CIP1 in a p53-independent manner, and that BRCA1 inhibits cell-cycle progression into the S-phase following its transfection into human cancer cells. BRCA1 does not inhibit S-phase progression in p21−/− cells, unlike p21+/+ cells, and tumour-associated, transactivation-deficient mutants of BRCA1 are defective in both transactivation of p21 and cell-cycle inhibition. These data suggest that one mechanism by which BRCA1 contributes to cell-cycle arrest and growth suppression is through the induction of p21.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Miki, Y. et al. Astrong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66–71 (1994).
    Article ADS CAS Google Scholar
  2. Futreal, P. A. et al. BRCA1 mutations in primary breast and ovarian carcinomas. Science 266, 120–122 (1994).
    Article ADS CAS Google Scholar
  3. Easton, D. F., Ford, D. & Bishop, D. T. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am. J. Hum. Genet. 56, 265–271 (1995).
    Article CAS Google Scholar
  4. Chen, Y. et al. Aberrant subcellular localization of BRCA1 in breast cancer. Science 270, 789–791 (1995).
    Article ADS CAS Google Scholar
  5. Scully, R. et al. Location of BRCA1 in human breast and ovarian cancer cells. Science 272, 123–125 (1996).
    Article ADS CAS Google Scholar
  6. Chapman, M. S. & Verma, I. M. Transcriptional activation by BRCA1. Nature 382, 678–679 (1996).
    Article ADS CAS Google Scholar
  7. Monteiro, A. N., August, A. & Hanafusa, H. Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc. Natl Acad. Sci. USA 93, 13595–13599 (1996).
    Article ADS CAS Google Scholar
  8. Scully, R. et al. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88, 265–275 (1997).
    Article CAS Google Scholar
  9. Gowen, L. C. et al. Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nature Genet. 12, 191–194 (1996).
    Article CAS Google Scholar
  10. Hakem, R. et al. The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell 85, 1009–1023 (1996).
    Article CAS Google Scholar
  11. Sherr, C. J. & Roberts, J. M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9, 1149–1163 (1995).
    Article CAS Google Scholar
  12. Zeng, Y.-X., Somasundaram, K., Prabhu, N. S., Krishnadasan, R. & El-Deiry, W. S. Detection and analysis of living, growth-inhibited mammalian cells following transfection. Biotechniques 23, 88–94 (1997).
    Article CAS Google Scholar
  13. El-Deiry, W. S. et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817–825 (1993).
    Article CAS Google Scholar
  14. Zhang, W. et al. p53-independent induction of WAF1/CIP1 in human leukeumia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res. 55, 668–674 (1995).
    CAS PubMed Google Scholar
  15. Waldman, T., Kinzler, K. W. & Vogelstein, B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res. 55, 5187–5190 (1995).
    CAS PubMed Google Scholar
  16. Vaughn, J. P. et al. BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells. Cell Growth Differ. 7, 711–715 (1996).
    CAS PubMed Google Scholar
  17. Gudas, J. M. et al. Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells. Cell Growth Differ. 7, 717–723 (1996).
    CAS PubMed Google Scholar
  18. Chen, Y. et al. BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner. Cancer Res. 56, 3168–3172 (1996).
    CAS PubMed Google Scholar
  19. Humphrey, J. S. et al. Human BRCA1 inhibits growth in yeast: Potential use in diagnostic testing. Proc. Natl Acad. Sci. USA 94, 5820–5825 (1997).
    Article ADS CAS Google Scholar
  20. Scully, R. et al. BRCA1 is a component of the RNA polymerase II holoenzyme. Proc. Natl Acad. Sci. USA 94, 5605–5610 (1997).
    Article ADS CAS Google Scholar
  21. Zeng, Y.-X., Somasundaram, K. & El-Deiry, W. S. AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expression. Nature Genet. 15, 78–82 (1997).
    Article CAS Google Scholar
  22. El-Deiry, W. S. et al. Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res. 55, 2910–2919 (1995).
    CAS PubMed Google Scholar
  23. Thakur, S. et al. Localization of BRCA1 and a splice variant identifies the nuclear localization signal. Mol. Cell. Biol. 17, 444–452 (1997).
    Article CAS Google Scholar
  24. Meyuhas, O. & Perry, R. P. Construction and identification of cDNA clones for mouse ribosomal proteins: application for the study of r-protein gene expression. Gene 10, 113–129 (1980).
    Article CAS Google Scholar
  25. Somasundaram, K. & El-Deiry, W. S. Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region. Oncogene 14, 1047–1057 (1997).
    Article CAS Google Scholar

Download references

Acknowledgements

This work was supported by grants from the NIH and the Breast Cancer Research Foundation to B.L.W. W.S.E.-D. is an assistant investigator of the Howard Hughes Medical Institute.

Author information

Author notes

  1. Kumaravel Somasundaram and Hongbing Zhang: These authors contributed equally to this study.

Authors and Affiliations

  1. Laboratory of Molecular Oncology and Cell Cycle Regulation, Howard Hughes Medical Institute, University of Pennsylvania School of Medicine, Philadelphia, 19104, Pennsylvania, USA
    Kumaravel Somasundaram, Yi-Xin Zeng, Gen Sheng Wu & Wafik S. El-Deiry
  2. Departments of Medicine, University of Pennsylvania School of Medicine, Philadelphia, 19104, Pennsylvania, USA
    Kumaravel Somasundaram, Hongbing Zhang, Yi-Xin Zeng, Yi Peng, Hongxiang Zhang, Gen Sheng Wu, Barbara L. Weber & Wafik S. El-Deiry
  3. Departments of Genetics, University of Pennsylvania School of Medicine, Philadelphia, 19104, Pennsylvania, USA
    Barbara L. Weber & Wafik S. El-Deiry
  4. Departments of Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, 19104, Pennsylvania, USA
    Barbara L. Weber & Wafik S. El-Deiry
  5. Brookdale Center for Developmental and Molecular Biology and Department of Medicine, The Mount Sinai School of Medicine, New York, 10029, New York, USA
    Yariv Houvras & Jonathan D. Licht

Authors

  1. Kumaravel Somasundaram
    You can also search for this author inPubMed Google Scholar
  2. Hongbing Zhang
    You can also search for this author inPubMed Google Scholar
  3. Yi-Xin Zeng
    You can also search for this author inPubMed Google Scholar
  4. Yariv Houvras
    You can also search for this author inPubMed Google Scholar
  5. Yi Peng
    You can also search for this author inPubMed Google Scholar
  6. Hongxiang Zhang
    You can also search for this author inPubMed Google Scholar
  7. Gen Sheng Wu
    You can also search for this author inPubMed Google Scholar
  8. Jonathan D. Licht
    You can also search for this author inPubMed Google Scholar
  9. Barbara L. Weber
    You can also search for this author inPubMed Google Scholar
  10. Wafik S. El-Deiry
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toWafik S. El-Deiry.

Rights and permissions

About this article

Cite this article

Somasundaram, K., Zhang, H., Zeng, YX. et al. Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiPl.Nature 389, 187–190 (1997). https://doi.org/10.1038/38291

Download citation

This article is cited by